Literature DB >> 1991122

Reassessment of the catalytic mechanism of glycogen debranching enzyme.

W Liu1, N B Madsen, C Braun, S G Withers.   

Abstract

The amylo-1,6-glucosidase catalytic activity of glycogen debranching enzyme allows it to hydrolyze alpha-D-glucosyl fluoride, in the absence or presence of glycogen or oligosaccharides, releasing equal amounts of fluoride and glucose at rates comparable to those seen with the natural substrates. 2-Deoxy-2-fluoro-alpha-D-glucosyl fluoride is found to be a poor substrate, rather than the covalent inhibitor that would be expected for a glucosidase which catalyzes hydrolysis of the glycosidic linkage with retention of anomeric configuration. In fact, analysis of the glucosidase reaction by NMR reveals that the debranching enzyme hydrolyzes the glycosidic linkage with inversion of configuration, releasing beta-D-glucose from both alpha-glucosyl fluoride and its natural substrate, the phosphorylase limit dextrin. In contrast, its transferase activity necessarily proceeds with retention of configuration. As has been seen with other "inverting" glycosidases, the debranching enzyme releases beta-D-glucose from beta-D-glucosyl fluoride in the presence of oligosaccharides such as maltohexaose and cyclomaltoheptaose but, unlike the others, not in their absence. An intermediate glucosyl-alpha-(1,6)-cyclomaltoheptaose has been detected by NMR analysis. In the presence of a water-soluble carbodiimide, a single mole of glycine ethyl ester is incorporated into each mole of the debranching enzyme, resulting in its inactivation when measured by the combined assay for both transferase and glucosidase activities. Measurement of the latter two activities independently indicates that it is the transferase activity which is inactivated, while the glucosidase activity, measured with alpha-D-glucosyl fluoride as substrate, is unaffected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991122     DOI: 10.1021/bi00219a036

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Structural insight into the bifunctional mechanism of the glycogen-debranching enzyme TreX from the archaeon Sulfolobus solfataricus.

Authors:  Eui-Jeon Woo; Seungjae Lee; Hyunju Cha; Jong-Tae Park; Sei-Mee Yoon; Hyung-Nam Song; Kwan-Hwa Park
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 2.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

3.  Mutation Analysis in Glycogen Storage Disease Type III Patients in the Netherlands: Novel Genotype-Phenotype Relationships and Five Novel Mutations in the AGL Gene.

Authors:  Christiaan P Sentner; Yvonne J Vos; Klary N Niezen-Koning; Bart Mol; G Peter A Smit
Journal:  JIMD Rep       Date:  2012-03-16

Review 4.  Structure and function of α-glucan debranching enzymes.

Authors:  Marie Sofie Møller; Anette Henriksen; Birte Svensson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

5.  A novel alpha-glucosidase from the acidophilic archaeon Ferroplasma acidiphilum strain Y with high transglycosylation activity and an unusual catalytic nucleophile.

Authors:  Manuel Ferrer; Olga V Golyshina; Francisco J Plou; Kenneth N Timmis; Peter N Golyshin
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

Review 6.  Approaches to labeling and identification of active site residues in glycosidases.

Authors:  S G Withers; R Aebersold
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

7.  Synthesis and kinetic evaluation of 4-deoxymaltopentaose and 4-deoxymaltohexaose as inhibitors of muscle and potato alpha-glucan phosphorylases.

Authors:  R Mosi; S G Withers
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

8.  Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.

Authors:  Alan Cheng; Mei Zhang; Minoru Okubo; Kaoru Omichi; Alan R Saltiel
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

9.  Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.

Authors:  A I Dagli; R T Zori; H McCune; T Ivsic; M K Maisenbacher; D A Weinstein
Journal:  J Inherit Metab Dis       Date:  2009-03-30       Impact factor: 4.982

10.  Starch- and glycogen-debranching and branching enzymes: prediction of structural features of the catalytic (beta/alpha)8-barrel domain and evolutionary relationship to other amylolytic enzymes.

Authors:  H M Jespersen; E A MacGregor; B Henrissat; M R Sierks; B Svensson
Journal:  J Protein Chem       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.